Advertisement
Advertisement

HRTX

HRTX logo

Heron Therapeutics, Inc.

1.73
USD
-0.05
-3.07%
Jul 31, 15:36 UTC -4
Closed
exchange

Pre-Market

1.50

-0.23
-13.29%

Heron Therapeutics, Inc. Profile

Info & Links

CEO

Craig Collard

Headquarters

100 REGENCY FOREST DRIVE, SUITE 300
CARY, NC 27518, UNITED STATES

Sector

Medical

Auditor

WithumSmith+Brown, PC

Share holders

68

Employees

122

Heron Therapeutics, Inc. Statistics

Valuation Measures

Market Capitalization2

228.85M

Enterprise Value

384.54M

Enterprise Value/EBITDA(ttm)

-194.61

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

73.79%

Operating Margin(ttm)

--

Profit Margin(ttm)

-6.16%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

-5.99%

Return on Assets(ttm)

--

Income Statement

Revenue(ttm)

148.52M

Revenue Per Share(ttm)

0.97

Gross Profit(ttm)

109.86M

EBITDA(ttm)3

-1.98M

Net Income Available to Common(ttm)

-7.78M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

--

52-Week Change

-41.75%

S&P 500 52-Week Change

16.39%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

152.56M

Dividend Yield

--

Float4

--

% Held by Insiders

--

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

50.68M

Total Cash Per Share(mrq)

0.33

Total Debt(mrq)

174.97M

Total Debt/Equity(mrq)

-614.93%

Current Ratio(mrq)

2.40%

Quick Ratio(mrq)

--

Book Value Per Share(mrq)

-0.19

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.04

Free Cash Flow(ytd)

-8.94M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement